Abramson Cancer Center At Penn Medicine
Clinical trials sponsored by Abramson Cancer Center At Penn Medicine, explained in plain language.
-
Promising drug shows hope for Hard-to-Treat prostate cancer
Disease control CompletedThis study tested a drug called niraparib in 11 men with advanced prostate cancer that was growing despite hormone therapy. All participants had previously received platinum chemotherapy. The goal was to see if niraparib could keep the cancer from progressing for at least 6 month…
Phase: PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated May 26, 2026 04:24 UTC
-
Heart shield for chemo: carvedilol may guard against toxicity
Disease control CompletedThis early-phase study tested whether the heart medication carvedilol could safely prevent heart damage in breast cancer patients receiving chemotherapy with doxorubicin and/or trastuzumab. Researchers assigned 68 women to either usual care or carvedilol based on their risk of he…
Phase: PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated May 26, 2026 04:21 UTC
-
Immunotherapy after treatment may keep limited lung cancer at bay
Disease control CompletedThis study looked at whether the immunotherapy drug pembrolizumab can help people with a limited form of lung cancer (oligometastatic NSCLC) that has already been treated. 51 adults received pembrolizumab every 3 weeks for up to 16 cycles. The main goal was to see how long it too…
Phase: PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated May 26, 2026 04:17 UTC
-
New study tests which program helps high-risk smokers quit for good
Disease control CompletedThis study compared four different smoking cessation programs to see which one works best for underserved smokers who are getting lung cancer screening. Over 3,200 participants from four U.S. health systems took part. The goal was to find the most effective way to help them quit …
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated May 26, 2026 03:56 UTC
-
New hope for BRCA breast cancer: triple-drug combo shows promise in early trial
Disease control CompletedThis early-phase trial tested a combination of three drugs—olaparib, palbociclib, and fulvestrant—in 9 people with advanced, hormone receptor-positive breast cancer who also have BRCA1 or BRCA2 mutations. The main goal was to see if the combination is safe and to measure how long…
Phase: PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Proton beam therapy shows promise for rare spine and skull base tumors
Disease control CompletedThis study tested a precise type of radiation called proton therapy for people with rare tumors called chordomas and chondrosarcomas. The goal was to see if it was safe and could be given without major side effects. 54 adults with these tumors in the skull base or spine took part…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Radiation and immune drugs join forces against tough cancers
Disease control CompletedThis early-phase trial tested whether combining a special type of radiation (hypofractionated radiotherapy) with two immunotherapy drugs (MEDI4736 and tremelimumab) is safe and tolerable for people with advanced melanoma, lung, breast, or pancreatic cancer that has spread. The st…
Phase: PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
New therapy helps smokers with HIV kick the habit
Disease control CompletedThis study tested a new type of counseling called BAPS to help smokers with HIV quit smoking. 651 participants were split into two groups: one received standard smoking cessation counseling, and the other received BAPS therapy. The goal was to see which approach led to more peopl…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
LGBTQ+ teens get tailored Anti-Vaping ads on social media
Prevention CompletedThis study tested whether anti-vaping social media messages designed specifically for sexual and gender minority (SGM) teens could prevent them from starting to vape. Over 1,100 SGM youth aged 13-20 who had not vaped recently received either tailored or generic messages. The goal…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Prevention
Last updated May 26, 2026 04:20 UTC
-
Virtual reality eases anxiety before radiation in small study
Symptom relief CompletedThis study tested whether using virtual reality (VR) for mindfulness and relaxation before radiation therapy is practical for cancer patients. Twenty-five adults scheduled for radiation simulation tried the VR program. The main goal was to see if at least 75% could complete the V…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Symptom relief
Last updated May 26, 2026 04:21 UTC
-
Can a simple nudge save lives? new study tests smarter messages to boost genetic testing before chemo
Knowledge-focused CompletedThis study looked at how to increase the number of patients who get DPYD testing before starting chemotherapy for gastrointestinal cancer. DPYD testing checks for gene changes that can cause severe or even deadly side effects from common chemo drugs. Researchers tested different …
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 04:24 UTC
-
Community program aims to boost lung cancer screening rates
Knowledge-focused CompletedThis study tested a community support program to help people attend lung cancer screening appointments. Researchers compared attendance rates among West Philadelphia residents who opted into the program, those who did not, and residents from another area. The goal was to see if t…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 04:24 UTC
-
Nudge study aims to boost cancer patient survey completion
Knowledge-focused CompletedThis study tested whether sending reminders to cancer patients and alerts to their nurses could increase how often patients complete symptom questionnaires. 476 adults starting a new cancer therapy were randomly assigned to usual care, reminders with alerts, or remote monitoring …
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 04:23 UTC
-
Healthy volunteers needed to Fine-Tune cancer blood test
Knowledge-focused CompletedThis study collected blood from 43 healthy adults aged 18-60 to serve as a comparison for a test that looks for cancer cells in the blood. Participants gave about 20 mL of blood at up to 20 visits. The goal was to help make the test more accurate for future cancer patients.
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 04:23 UTC
-
Sharper scans could mean smarter staging for lung cancer
Knowledge-focused CompletedThis study looked at ways to improve PET/CT scans for people with non-small cell lung cancer. The goal was to see if changing how the images are taken and processed could make staging more accurate. Thirty adults took part, and the focus was on safety and image quality, not on tr…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 04:23 UTC
-
Peer power: can patient ambassadors boost cancer trial enrollment?
Knowledge-focused CompletedThis study tested whether trained patient ambassadors could help more people with advanced gynecologic cancer learn about and join clinical trials. 23 patients participated in discussions with an ambassador. The goal was to see if this approach is practical and acceptable, not to…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 04:19 UTC
-
Which radiation is safer for the heart? new study investigates
Knowledge-focused CompletedThis study looked at 172 breast cancer patients to see how two types of radiation therapy—proton and photon—affect heart health. Researchers measured heart function and blood markers before, during, and up to one year after treatment. The goal was to understand which method might…
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 04:19 UTC
-
Walking for a cause: study tests if games and charity donations get families moving
Knowledge-focused CompletedThis study tested whether social incentives, like gamification and donations to charity, can help low-income families increase their daily walking. 779 participants wore Fitbits to track steps over 12 months. The goal was to see if these strategies make physical activity more eng…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 04:17 UTC
-
Chatbot penny aims to reconnect cancer survivors with life-saving follow-up care
Knowledge-focused CompletedThis study tested a chatbot named Penny to see if it could help adults who had cancer as children or young adults get back into regular follow-up care. Participants had not seen a doctor for their cancer history in at least three years. The chatbot sent text messages to help them…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 04:15 UTC
-
Does pack color change how you smoke? study investigates
Knowledge-focused CompletedThis study looked at whether the color of a cigarette package changes how people smoke low-nicotine cigarettes. Researchers measured daily cigarette use, puffing behavior, and exposure to harmful chemicals in 219 adult smokers over 35 days. The goal was to understand if package c…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 04:12 UTC
-
New tool helps seniors with low health literacy make smarter cancer screening choices
Knowledge-focused CompletedThis study tested a decision aid to help adults aged 76-85 with low health literacy decide about colorectal cancer screening. 60 participants from community health centers used the tool to see if it changed their screening intentions and knowledge. The goal was to improve informe…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 03:56 UTC
-
Free rides boost lung cancer screening in philly
Knowledge-focused CompletedThis project offered free transportation and scheduling help to people in Philadelphia who needed lung cancer screening. The goal was to see if these services helped more people attend their appointments. The study included 252 participants and compared attendance among those who…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 03:54 UTC
-
New tool helps cancer patients voice their wishes to doctors
Knowledge-focused CompletedThis study tested a simple way to help hospitalized patients with advanced lung or gastrointestinal cancers talk about their care goals with their cancer doctor after leaving the hospital. About 80 patients took part, with half completing a short survey about their preferences, w…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC
-
CAR T-Cell therapy: hidden heart risks revealed in new study
Knowledge-focused CompletedThis study followed 44 adults with leukemia or lymphoma who received CAR T-cell therapy to see how their hearts were affected. Researchers used heart scans, blood tests, and quality-of-life surveys to track heart function over time. The goal was to find out how often heart proble…
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated May 22, 2026 14:01 UTC
-
Can a simple message boost lifesaving genetic tests?
Knowledge-focused CompletedThis study tested different ways to encourage genetic testing in people at high risk for breast or ovarian cancer. Over 1,300 participants received either a direct message through an online patient portal or a reminder to their doctor during a visit. The goal was to see which met…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated May 20, 2026 11:55 UTC
-
Nudge study aims to boost MRI use in women with dense breasts
Knowledge-focused CompletedThis study tested whether sending reminders (nudges) to doctors, patients, or both could increase the number of women with extremely dense breasts who get a breast MRI. Over 1,300 women aged 40-74 took part. The goal was to see if these nudges help catch cancer earlier, especiall…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated May 19, 2026 12:00 UTC
-
AI and personal guidance boost cancer screening in underserved neighborhoods
Knowledge-focused CompletedThis study tested a program that uses computer algorithms and patient navigators to help people in low-income areas complete their colorectal cancer screening. 385 adults from specific Philadelphia zip codes who had not finished a colonoscopy or stool test were included. The goal…
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated May 18, 2026 12:11 UTC
-
Robot Head-Holder could make brain radiation safer
Knowledge-focused CompletedThis study tested a robotic platform that uses motion cameras to keep a person's head still in real time. Twenty healthy volunteers participated, and no radiation was used. The goal was to collect motion data to help develop better head stabilization methods for future brain radi…
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated May 18, 2026 12:01 UTC
-
New PET scan tracks immune cells in melanoma patients
Knowledge-focused CompletedThis early-phase study tested a special PET/CT scan that uses a tracer to detect immune cells (CD8+ T cells) in tumors. Six adults with advanced melanoma who were also on immunotherapy and hydroxychloroquine received the scan before and after treatment. The goal was to see if cha…
Phase: EARLY_PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC